FdaApplication
NDA 206056
Identifiers
- fda_app_no: NDA206056
Properties
| Property | Value |
|---|---|
| applicant_name | B BRAUN MEDICAL INC |
| application_type | NDA |
| approval_date | 2025-04-03 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | POWDER;INTRAVENOUS |
| PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | POWDER;INTRAVENOUS |
| PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | POWDER;INTRAVENOUS |
3 products